Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus

This publication has 23 references indexed in Scilit:

• Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA
  Published by American Medical Association (AMA) ,1996
• In Vivo Resistance to a Human Immunodeficiency Virus Type 1 Proteinase Inhibitor: Mutations, Kinetics, and Frequencies
  The Journal of Infectious Diseases, 1996
• A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)
  AIDS, 1996
• Protease inhibitors fly through FDA
  The Lancet, 1996
• Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir
  The Journal of Infectious Diseases, 1996
• Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials
  Antiviral Research, 1996
• Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4 + lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity
  Antiviral Research, 1996
• In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
  Nature, 1995
• HIV Drug Resistance
  AIDS Research and Human Retroviruses, 1992
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989